Pacific Biosciences of California, Inc. (PACB)

2.015 +0.08 (+3.87%) USD  |  NASDAQ  |  Jan 12, 16:00
2.00 -0.02 (-0.74%) After-Hours: 17:34
More

Pacific Biosciences of California Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for PACB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Intellia Therapeutics, Inc. Upgrade
Twist Bioscience Corp. Upgrade
Beam Therapeutics, Inc. Upgrade
Boston Scientific Corp. Upgrade
Bruker Corp. Upgrade